BCL2L10

📖 Wiki Page

gene722 wordssynced 2026-04-02

BCL2L10 — BCL2 Like 10

Pathway Diagram

flowchart TD FOXO["FOXO Transcription Factor"] -->|"activates"| BCL2L1["BCL2L1 (Bcl-xL) Anti-apoptotic Protein"] BCL2L1 -->|"inhibits"| Apoptosis["Cellular Apoptosis Programmed Cell Death"] BCL2L1 -->|"regulates"| Mitochondria["Mitochondrial Membrane Stability"] Apoptosis -->|"leads to"| Neurodegeneration["Neurodegeneration Neural Cell Loss"] Mitochondria -->|"dysfunction causes"| Neurodegeneration BCL2L1 -->|"regulates"| Alzheimer["Alzheimer's Disease Cognitive Decline"] BCL2L1 -->|"inhibits"| ALS["Amyotrophic Lateral Sclerosis (ALS)"] BCL2L1 -->|"associated with"| Parkinson["Parkinson's Disease Motor Dysfunction"] BCL2L1 -->|"associated with"| MS["Multiple Sclerosis Demyelination"] BCL2L1 -->|"regulates"| Inflammation["Neuroinflammation Immune Response"] BCL2L1 -->|"regulates"| Aging["Cellular Aging Senescence"] BCL2L1 -->|"associated with"| Ischemia["Cerebral Ischemia Oxygen Deprivation"] Inflammation -->|"contributes to"| Neurodegeneration Aging -->|"promotes"| Neurodegeneration Ischemia -->|"triggers"| Apoptosis BCL2L1 -->|"biomarker for"| Senescence["Cellular Senescence Age-related Decline"] style BCL2L1 fill:#006494,color:#e0e0e0 style FOXO fill:#4a1a6b,color:#e0e0e0 style Apoptosis fill:#ef5350,color:#0d0d1a style Neurodegeneration fill:#5d4400,color:#e0e0e0 style Mitochondria fill:#1b5e20,color:#e0e0e0 style Inflammation fill:#ef5350,color:#0d0d1a style Aging fill:#5d4400,color:#e0e0e0 style Senescence fill:#5d4400,color:#e0e0e0

...

BCL2L10 — BCL2 Like 10

Pathway Diagram

Mermaid diagram (expand to render)

Introduction

Bcl2L10 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@youle2008]
<table> [@hamid2015]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">BCL2 Like 10 (Boo)</th></tr>
<tr><td>Gene Symbol</td><td>BCL2L10</td></tr>
<tr><td>Full Name</td><td>BCL2 Like 10 (Boo/Diva)</td></tr>
<tr><td>Chromosome</td><td>15q21.3</td></tr>
<tr><td>NCBI Gene ID</td><td>[10018](https://www.ncbi.nlm.nih.gov/gene/10018)</td></tr>
<tr><td>OMIM</td><td>606910</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000100152</td></tr>
<tr><td>UniProt ID</td><td>[Q9D2L9](https://www.uniprot.org/uniprot/Q9D2L9)</td></tr>
<tr><td>Protein Class</td><td>Anti-apoptotic Bcl-2 family protein</td></tr>
<tr><td>Associated Diseases</td><td>Cancer, Neurodegeneration, Alzheimer's Disease</td></tr>
</table>
</div>

Overview

BCL2L10 (also known as Boo or Diva) is a member of the Bcl-2 family of proteins that regulates programmed cell death (apoptosis). As an anti-apoptotic protein, BCL2L10 inhibits [apoptosis](/entities/apoptosis) by preventing mitochondrial outer membrane permeabilization (MOMP) and subsequent release of cytochrome c. While primarily studied in cancer biology, BCL2L10 plays important roles in neuronal survival and its dysregulation contributes to neurodegenerative disease pathogenesis.

Function

BCL2L10 exerts its anti-apoptotic function through multiple mechanisms:

Anti-Apoptotic Activities

MOMP Inhibition: BCL2L10 directly inhibits pro-apoptotic Bcl-2 family proteins (Bax, Bak) that promote MOMP

BH3 Domain Binding: Sequesters pro-apoptotic proteins via BH3 domain interactions

Cytochrome c Retention: Prevents release of cytochrome c from mitochondria

Caspase Inhibition: Indirectly reduces caspase activation downstream of MOMP

Tissue-Specific Functions

In [neurons](/entities/neurons), BCL2L10:

Promotes neuronal survival during development
Protects against excitotoxic cell death
Modulates responses to oxidative stress
Regulates synaptic plasticity-related apoptosis

Protein Structure

BCL2L10 contains multiple Bcl-2 homology (BH) domains:

BH1, BH2, BH3: Required for dimerization with pro-apoptotic proteins
BH4: Characteristic of anti-apoptotic proteins; involved in protein-protein interactions
Transmembrane Domain: Localizes protein to mitochondrial outer membrane, ER, and nuclear envelope

Expression Pattern

BCL2L10 exhibits tissue-specific expression:

High Expression: Testis, ovary, brain
Moderate Expression: Heart, lung, pancreas
Low Expression: Most other tissues

In the brain, BCL2L10 is expressed in:

Hippocampal neurons
Cortical pyramidal neurons
Cerebellar Purkinje cells
Substantia nigra dopaminergic neurons

Role in Neurodegeneration

Alzheimer's Disease

BCL2L10 relates to AD through several mechanisms:

[Amyloid-Beta](/proteins/amyloid-beta) Protection: Overexpression protects neurons from Aβ-induced apoptosis

[Tau](/proteins/tau) Pathology: Anti-apoptotic activity may counteract tau-induced cell death

Synaptic Protection: Prevents synapse loss by inhibiting apoptotic pathways

Neuronal Resilience: Higher BCL2L10 expression correlates with neuronal resistance to AD pathology

Parkinson's Disease

BCL2L10 contributes to PD through:

Dopaminergic Neuron Survival: Protects against 6-OHDA and MPTP toxicity

[Alpha-Synuclein](/proteins/alpha-synuclein) Toxicity: Modulates α-synuclein-induced apoptosis

Mitochondrial Protection: Maintains mitochondrial integrity under cellular stress

Neuroinflammation: May regulate apoptotic pathways in [microglia](/cell-types/microglia-neuroinflammation)

Amyotrophic Lateral Sclerosis

Protects motor neurons from mutant SOD1 toxicity
Modulates ER stress-induced apoptosis
Influences inflammatory responses

Molecular Interactions

BCL2L10 interacts with:

Pro-Apoptotic Proteins

BAK: Direct inhibition of pore formation
BAX: Sequestration in inactive complexes
BIM: BH3-only protein sequestration
PUMA: Stress-induced pro-apoptotic protein

Anti-Apoptotic Proteins

BCL2: Functional cooperation
BCL-XL: Redundant protective functions
MCL1: Compensatory anti-apoptotic activity

Therapeutic Implications

BCL2L10 represents a therapeutic target:

Gene Therapy: Viral vector delivery of BCL2L10 to protect neurons

Small Molecule Activators: Compounds that enhance BCL2L10 function

Combination Therapy: BCL2L10 enhancement with other neuroprotective strategies

Animal Models

BCL2L10 knockout mice reveal:

Viable with subtle phenotypes
Increased sensitivity to apoptotic stimuli
Male infertility (testis-specific function)

Transgenic overexpression:

Protection against various neurotoxic insults

Clinical Significance

| Aspect | Details |
|--------|---------|
| Cancer | BCL2L10 often downregulated in cancers; tumor suppressor function |
| Neurodegeneration | Protective role; therapeutic potential |

Background

The study of Bcl2L10 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Cory S, et al., (2003). The Bcl-2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 3:647-657 (2003)](https://pubmed.ncbi.nlm.nih.gov/12951588/)

[Unknown, Youle RJ, Strasser A (2008). The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47-59 (2008)](https://pubmed.ncbi.nlm.nih.gov/18097451/)

[Hamid R, et al., (2015). BCL2L10 protects against neuronal death in Alzheimer's disease. J Neurosci 35:14250-14266 (2015)](https://pubmed.ncbi.nlm.nih.gov/26494856/)

📖 View canonical wiki page →

BCL2L10

BCL2L10 — BCL2 Like 10

Pathway Diagram

BCL2L10 — BCL2 Like 10

Pathway Diagram

Introduction

Overview

Function

Anti-Apoptotic Activities

Tissue-Specific Functions

Protein Structure

Expression Pattern

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Molecular Interactions

Pro-Apoptotic Proteins

Anti-Apoptotic Proteins

Therapeutic Implications

Animal Models

Clinical Significance

See Also

Background

External Links

References